TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+44.59%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$740M
AUM Growth
+$740M
(+36%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$36.3M |
| 2 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$6.13M |
| 3 |
Cellectar Biosciences
CLRB
|
$1.48M |
Top Sells
| 1 |
Equillium
EQ
|
$379K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $516M | 69.79% |
14,075,269
+989,231
| +8% | +$36.3M |
|
2
Heron Therapeutics
HRTX
$207M
| $107M | 14.43% |
5,744,096
| – | – |
|
|
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $45.7M | 6.17% |
4,938,893
| – | – |
|
4
Rocket Pharmaceuticals
RCKT
$354M
| $44.5M | 6.01% |
2,965,485
| – | – |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $10.3M | 1.4% |
111,844
| – | – |
|
|
GTHX
6
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $6.13M | 0.83% |
+200,000
| New | +$6.13M |
|
7
Puma Biotechnology
PBYI
$254M
| $4.44M | 0.6% |
349,400
| – | – |
|
8
Prothena Corp
PRTA
$441M
| $3.42M | 0.46% |
323,823
| – | – |
|
|
9
Cellectar Biosciences
CLRB
$15.5M
| $1.48M | 0.2% |
+680,000
| New | +$1.48M |
|
|
ISEE
10
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $780K | 0.11% |
600,000
| – | – |
|
|
11
Equillium
EQ
$62.2M
| – | – |
-47,343
| Closed | -$379K |
|